FDA Investigator Carl A Anderson
Carl A Anderson has inspections in 9 countries as of 14 Jul 2023. Carl A Anderson has collaborated with a combined 3011 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
112
Last Inspection Date:
14 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Switzerland,
Canada,
Sweden,
Italy,
France,
Ireland,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alan D Grupe,
Alexander M Kay,
Anastasia G Lolas,
Anastasia M Shields,
Andrew R Wasko,
Anita Narula, PhD,
Ann Marie Montemurro,
Ashleigh P Barkans,
Astrida B Mattson,
Azza Talaat,
B Katie Alford,
Barbar J Breithaupt,
Barbara Janine Breithaupt,
Bonnie E Conley,
Bonnie E Pierson,
Brandon C Heitmeier,
Brenda K Alford,
Brenda L Reihing,
Carol A Gripp,
Catherine J Laufmann,
Charisse K Green,
Charles I Ann,
Charles M Edwards,
Charles R Bonapace, PhD,
Christine W Twohy,
Christopher R Czajka,
Connie P Rezendes,
Ct Viswanathan, PhD,
Cynthia J Lee, MS,
Cynthia L Gorveatt,
Da Lin Yao, MD, PhD,
Darla J Christopher,
David J Gomes,
Dawn E Barkans,
Deborah A Nebenzahl,
Dennis G Kawabata,
Dennis R Hudson,
Deyaa Shaheen,
Dolores E Price,
Donald B Mckechnie,
Douglas C Kovacs,
Dr. Carmelo Rosa,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edward D Harris,
Edward D Mcdonald,
Edward Deberry,
Elizabeth Ll Edwards,
Elizabeth S Howell,
Eric S Weilage,
Erika V Butler,
Erin M Mcdowell,
Gayle S Lawson,
Gerard Pde Leon,
Gloria J Baca, MS,
Gordon T Wales,
Grace P Santos,
Gwyn G Dickinson,
Heika R Bounds,
Heika R Tait,
Helen B Ricalde,
Hugh A Grimoldby,
Hugh Grimoldby,
Hugh M Mcclure, II,
Jacqueline A O'shaughnessy, PhD,
James A Jagon,
James A Lane,
James C Henry,
Jane M Krais,
Jane M Kreis,
Jennifer D Hollstrom,
Joey V Quitania,
Jonathan T Little,
Jose A Cruz,
Jose Acruz Gonzalez,
Jose M Cayuela,
Julian C Hanson,
Julie D Bringger,
Karen L Kosar,
Katherine E Jacobitz,
Kathryn A Krentz,
Kent C Faul,
Kevin D Kallander,
Kim Lthomas Cruse,
Larry K Austin,
Laurie B Frazier,
Lawrence Y Lee, PhD,
Linda S Leja,
Lisa K Capron,
Lori J Silverstein,
Lorna F Jones,
Marcelo O Mangalindan, Jr,
Maria Pkelly Doggett, MBA,
Marie F Morin,
Marijo B Kambere, PhD,
Mark W Babbitt,
Matthew R Dionne,
Maxwell Van Tassell, PhD,
Maya M Davis,
Michael F Skelly, PhD,
Michael J Lackey,
Michael J Nerz,
Michael L Casner,
Mihaly S Ligmond,
Minh D Phan,
Mra Davism,
Mra Mcculloughj,
Nancy A Saxenian Emmons,
Nancy E Byerly,
Nancy G Schmidt,
Nancy M Espinal,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Paul A Bonneau,
Paul F Rader,
Peter C Chow,
Peter Kessler, PhD,
Peter R Lenahan,
Prabhu P Raju,
Ramesh Potla, PhD,
Randy L Self,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Robert C Coleman,
Robert D Tollefsen,
Robert J Martin,
Robert M Tillman,
Rocco C Black,
Russell K Riley,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Savini,
Scott A Nabe,
Sharon I Gundersen,
Sharon K Thoma, PharmD,
Sherri N Rohlf, MD,
Sidney B Priesmeyer,
Stanley B Eugene, BS, BME,
State Agency,
Stephen D Brown,
Stephen R Souza,
Steven D Kehoe,
Stuart W Russell,
Sue Lee Chan,
Sunitha K Rajaram, PhD,
Susan M Jackson,
Susan P Bruederle,
Susanna E Ford, Analyst,
Terri L Dodds,
Thomas E Friel,
Timothy T Kapsala,
Tracy K Li,
Truong Xuan Nguyen (Andy),
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
William V Millar,
Williamsra,
Xiaojun Yan,
Yanming An, PhD,
Yasamin Ameri,
Yong Hu,
Yumi J Hiramine,
Zhong Li, PhD
Carl A Anderson's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more